We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

138 hedge funds and large institutions have $227M invested in Viking Therapeutics in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 39 increasing their positions, 52 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

320% more call options, than puts

Call options by funds: $7.14M | Put options by funds: $1.7M

4% less funds holding

Funds holding: 144 → 138 (-6)

7.54% less ownership

Funds ownership: 56.03% → 48.49% (-7.5%)

13% less capital invested

Capital invested by funds: $260M → $227M (-$33.3M)

25% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 20

25% less repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 52

Holders
138
Holders Change
-6
Holders Change %
-4.17%
% of All Funds
2.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
39
Reduced
52
Closed
20
Calls
$7.14M
Puts
$1.7M
Net Calls
+$5.44M
Net Calls Change
-$935K

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$1.94M
2
Goldman Sachs
Goldman Sachs
New York
+$1.44M
3
Citadel Advisors
Citadel Advisors
Florida
+$663K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$568K
5
PP
PDT Partners
New York
+$564K

Top Sellers

1
State Street
State Street
Massachusetts
-$10.7M
2
BBA
Baker Bros. Advisors
New York
-$2.3M
3
Two Sigma Investments
Two Sigma Investments
New York
-$1.75M
4
Aviva
Aviva
United Kingdom
-$1.31M
5
IC
Ikarian Capital
Texas
-$1.19M
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
101
Barclays
United Kingdom
$57K -$429K -72,283 -88%
Zurich Cantonal Bank
102
Zurich Cantonal Bank
Switzerland
$49K – – –
AIP
103
Ameritas Investment Partners
Nebraska
$33K – – –
US Bancorp
104
US Bancorp
Minnesota
$30K -$291 -49 -1%
TRCT
105
Tower Research Capital (TRC)
New York
$28K -$12.8K -2,148 -31%
Carson Wealth (CWM LLC)
106
Carson Wealth (CWM LLC)
Nebraska
$24K – – –
Canada Life
107
Canada Life
Manitoba, Canada
$23K – – –
Rockefeller Capital Management
108
Rockefeller Capital Management
New York
$16K +$11.9K +2,000 +276%
IA
109
IFP Advisors
Florida
$15K -$107 -18 -0.6%
PGAM
110
Princeton Global Asset Management
New Jersey
$15K – – –
FPS
111
Fieldpoint Private Securities
Connecticut
$14K -$184 -31 -1%
PNC Financial Services Group
112
PNC Financial Services Group
Pennsylvania
$12K +$2.97K +500 +33%
APA
113
American Portfolios Advisors
New York
$12K – – –
SWA
114
SOA Wealth Advisors
New York
$10K – – –
KTC
115
Kistler-Tiffany Companies
Pennsylvania
$9K – – –
PA
116
Parallel Advisors
California
$9K – – –
First Manhattan
117
First Manhattan
New York
$5K +$5.94K +1,000 New
FHA
118
First Horizon Advisors
Tennessee
$4K – – –
LC
119
Lindbrook Capital
California
$4K – – –
MA
120
Montag & Associates
Georgia
$4K – – –
DFCM
121
Dark Forest Capital Management
Puerto Rico
$4K +$3.9K +656 New
CFD
122
Creative Financial Designs
Indiana
$3K – – –
HI
123
Harbour Investments
Wisconsin
$3K – – –
PWM
124
Prentice Wealth Management
New York
$3K – – –
ASN
125
Advisory Services Network
Georgia
$3K +$2.97K +500 New
3 4
5
6 7

VKTX Hedge Fund Activity: Q2 2021 in Review

138 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q2 2021, worth a combined $227M — down 13% from $260M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of VKTX and 15 opened new positions — a net loss of 5 holders — while 52 trimmed existing stakes and 39 added.

The largest buyer was Morgan Stanley, adding an estimated $1.94M. The largest seller was State Street, cutting an estimated $10.7M.

  • 138 institutional investors held Viking Therapeutics (VKTX) as of Q2 2021, down from 144 in Q1 2021.
  • Funds reported $227M of Viking Therapeutics stock for Q2 2021, down 13% quarter-over-quarter.
  • 15 funds opened new Viking Therapeutics positions in Q2 2021 and 20 closed out, a net change of -5 holders.
  • The largest Viking Therapeutics buyer in Q2 2021 was Morgan Stanley, an estimated $1.94M added.
  • The largest Viking Therapeutics seller in Q2 2021 was State Street, an estimated $10.7M sold.

Based on aggregated 13F filings for Q2 2021.